Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

July 1, 2023

Conditions
VitiligoPediatric ALLDermatologic DiseaseAutoimmune Diseases
Interventions
DEVICE

exciplex

exciplex, excimer lamp 308nm produced by clarteis

DRUG

Tacrolimus ointment

tacrolimus monohydrate ointment 0.1% TACRUS

Trial Locations (1)

21410

King Abdullah University Hospital, Ar Ramtha

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Clarteis

INDUSTRY